Business
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
Conference call and webcast to take place on Wednesday, May 14, 2025, at 4:30 p.m. ET
About this update from Oncolytics Biotech Inc.
[{"type":"text","content":"Conference call and webcast to take place on Wednesday, May 14, 2025, at 4:30 p.m. ET","length":85,"tagName":"p","attribs":{}},{"type":"image","alt":"Oncolytics Biotech® Inc. Logo (PRNewsfoto/Oncolytics Biotech® Inc.)","displaySize":"","headline":null,"caption":"Oncolytics Biotech® Inc. Logo (PRNewsfoto/Oncolytics Biotech® Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":174,"url":"https://media.zenfs.com/en/prnewswire.com/caf9efe53f239ce497937f5fab3fe90d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/dOUtzp14m4TWUZEBzfpHDw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTMwNztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/caf9efe53f239ce497937f5fab3fe90d","width":400,"height":174}},"href":"https://mma.prnewswire.com/media/2408622/Oncolytics_Biotech_Inc_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"SAN DIEGO and CALGARY, AB, May 6, 2025 Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it will host a conference call and webcast on Wednesday, May 14, 2025, at 4:30 p.m. ET to discuss a corporate update and financial results for the first quarter of 2025.","length":363,"tagName":"p"},{"type":"text","content":"Conference Call & Webcast","length":29,"tagName":"p"},{"type":"text","content":"Date: Wednesday, May 14, 2025Time: 4:30 p.m. ETDial In – North American Toll-Free: (888) 510-2154Dial In – International: (437) 900-0527RapidConnect: to join the conference call without operator assistance, please click hereConference ID (if needed): 28038Webcast: please click here","length":298,"tagName":"p"},{"type":"text","content":"A webcast of the call will also be available on the Investor Relations page of Oncolytics' website, available by clicking here, and will be archived for three months. A dial-in replay will be available for one week and can be accessed by dialing (888) 660-6345 (North America) or (289) 819-1450 (International) and using replay code: 28038#.","length":350,"tagName":"p"},{"type":"text","content":"About Oncolytics Biotech Inc.Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Ph...